Kintara Therapeutics, Inc. Profile Avatar - Palmy Investing

Kintara Therapeutics, Inc.

Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targe…

Biotechnology
US, San Diego [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of KTRA's Analysis
CIK: 1498382 CUSIP: 49720K101 ISIN: US49720K2006 LEI: - UEI: -
Secondary Listings
KTRA has no secondary listings inside our databases.